For this reason, the simple, direct, reliable, and cost-effective detection and quantification of P-gp in tumor cells, and more particularly in tumoral masses, represents a relevant challenge for optimizing treatment efficacy and patient care while limiting the risk of therapeutic failure. The gene discussed is PGP; the disease is neoplasm.